THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS. (Q48079070)

8 February 2018

title

THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS' PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS. (English)

1 reference

8 February 2018

author

Leslie Citrome

4

1 reference

8 February 2018

author name string

Joseph F Goldberg

1

1 reference

8 February 2018

Marlene P Freeman

2

1 reference

8 February 2018

Richard Balon

3

1 reference

8 February 2018

Michael E Thase

5

1 reference

8 February 2018

John M Kane

6

1 reference

8 February 2018

Maurizio Fava

7

1 reference

8 February 2018

publication date

30 June 2015

1 reference

8 February 2018

published in

Depression and Anxiety

1 reference

8 February 2018

volume

32

1 reference

8 February 2018

issue

8

1 reference

8 February 2018

page(s)

605-613

1 reference

8 February 2018

Current status of augmentation and combination treatments for major depressive disorder: a literature review and a proposal for a novel approach to improve practice.

cites work

1 reference

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

Medication augmentation after the failure of SSRIs for depression.

21 January 2018

1 reference

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features

21 January 2018

1 reference

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

Empirical testing of two models for staging antidepressant treatment resistance.

21 January 2018

1 reference

Do the old psychostimulant drugs have a role in managing treatment-resistant depression?

21 January 2018

1 reference

Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial

21 January 2018

1 reference

Switching Antidepressants After a First Selective Serotonin Reuptake Inhibitor in Major Depressive Disorder

21 January 2018

1 reference

Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials

21 January 2018

1 reference

Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report.

21 January 2018

1 reference

Correlates and outcomes of depressed out-patients with greater and fewer anxious symptoms: a CO-MED report.

21 January 2018

1 reference

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study.

21 January 2018

1 reference

Review of atypical antipsychotics in anxiety

21 January 2018

1 reference

Efficacy of Bupropion and the Selective Serotonin Reuptake Inhibitors in the Treatment of Major Depressive Disorder With High Levels of Anxiety (Anxious Depression)

21 January 2018

1 reference

Treatment outcome validation of DSM-III depressive subtypes. Clinical usefulness in outpatients with mild to moderate depression.

21 January 2018

1 reference

A multiple-dose, controlled study of phenelzine in depression-anxiety states.

21 January 2018

1 reference

Response to phenelzine and amitriptyline in subtypes of outpatient depression.

21 January 2018

1 reference

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

21 January 2018

1 reference

Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

21 January 2018

1 reference

Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety

21 January 2018

1 reference

Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project

21 January 2018

1 reference

Adherence to guidelines by French psychiatrists in their real world of clinical practice

21 January 2018

1 reference

Which physician and practice characteristics are associated with adherence to evidence-based guidelines for depressive and anxiety disorders?

21 January 2018

1 reference

Use of treatment guidelines in clinical decision making in bipolar disorder: a pilot survey of clinicians

21 January 2018

1 reference

High dose tranylcypromine therapy for refractory depression.

21 January 2018

1 reference

High-dose desvenlafaxine in outpatients with major depressive disorder

21 January 2018

1 reference

Is dose escalation of antidepressants a rational strategy after a medium-dose treatment has failed? A systematic review

21 January 2018

1 reference

Preliminary survey of office-based opioid treatment practices and attitudes among psychiatrists never receiving buprenorphine training to those who received training during residency

21 January 2018

1 reference

Prescribing of phosphodiesterase-5 inhibitors among psychiatrists.

21 January 2018

1 reference

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report

21 January 2018

1 reference

7 January 2021

Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review

1 reference

7 January 2021

Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians

1 reference

7 January 2021

Why isn't bupropion the most frequently prescribed antidepressant?

1 reference

7 January 2021

Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants

1 reference

7 January 2021

Treatment with venlafaxine extended release after SSRI nonresponse or intolerance: a randomized comparison of standard- and higher-dosing strategies

1 reference

7 January 2021

Declining participation in research studies

1 reference

7 January 2021

Identifiers

DOI

10.1002/DA.22378

1 reference

8 February 2018

PubMed ID

26129956

1 reference

8 February 2018